Test Price
2,800 AED✅ Home Collection Available
DCX Gene Lissencephaly, X-linked Type 1 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين DCX لاضطراب الليسينسيفالي المرتبط بالكروموسوم X من النوع الأول في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Sequencing Lab (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Paid Hospital-Grade Home Collection (8 AM – 11 PM) by DHA-licensed phlebotomists using ISO cold‑chain transport.
Clinical Guidance: Telephonic Post‑Test Result Interpretation session with a senior genetic counsellor.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ضمان الدقة: حساسية تشخيصية بنسبة 99.9% عبر مختبر معتمد وفق الأيزو 9001:2015 (شهادة INT/EGQ/2509DA/3139).
خدمات لوجستية متميزة: سحب منزلي على مستوى المستشفى بواسطة فنيين مرخصين من هيئة الصحة بدبي مع نقل مبرد وفق معايير الأيزو.
الإرشاد السريري: استشارة هاتفية بعد النتيجة لتفسيرها مع استشاري وراثة معتمد.
التأمين: التحقق المباشر من التغطية التأمينية عبر واتساب +971 54 548 8731.
Clinical Overview
The DCX Gene Lissencephaly, X-linked Type 1 NGS Test employs high-coverage next‑generation sequencing to identify pathogenic variants in the DCX gene, the definitive cause of classic lissencephaly and subcortical band heterotopia. This DHA‑compliant assay combines Illumina NovaSeq 6000 technology with Sanger confirmation, offering unparalleled diagnostic precision for paediatric, neurological, and genetic counselling workflows across the UAE.
يعتمد اختبار جين DCX لتشخيص الليسينسيفالي المرتبط بالكروموسوم X من النوع الأول على تقنية التسلسل الجيني من الجيل التالي مع تأكيد بواسطة سانجر، مما يوفر تشخيصاً قاطعاً ومطابقاً لإرشادات هيئة الصحة بدبي لعام 2026.
| Feature | Our Test (DCX NGS) | Closest Alternative (Single‑Site Sanger) |
|---|---|---|
| Precision | >99.9% analytical sensitivity for all exonic variants | Limited to known familial mutations; 95% for targeted site |
| Method | NGS (Illumina NovaSeq) + Sanger confirmation, >1000× mean depth | Sanger sequencing of single amplicon |
| Turnaround Time | 3–4 weeks | 2–4 weeks |
| Regulatory Approval | ISO 9001:2015, DHA facility licence 9834453 | Often lacks ISO certification; limited to single‑lab validation |
Physician Insight & Safety Protocol
“As a Consultant Pediatrician, I have witnessed the transformative impact of a molecularly confirmed diagnosis in lissencephaly. The DCX NGS test eliminates diagnostic uncertainty and empowers families with accurate recurrence risk counselling. However, a negative result does not exclude other genetic aetiologies—all findings must be integrated with the child’s neuroimaging and clinical trajectory.”
— Dr. Prabhakar Reddy, DHA Licence 61713011
Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Infants requiring intensive care whose clinical instability precludes safe phlebotomy.
- Exclusion: Inability to obtain blood sample or a DNA FTA card; severe coagulopathy without physician clearance.
- ER Red Flag: New‑onset seizures, persistent vomiting, lethargy, or bulging fontanelle in an infant with suspected lissencephaly — seek immediate emergency care.
- ER Red Flag: Signs of raised intracranial pressure (high-pitched cry, sunsetting eyes) after diagnosis; do not wait for test results.
Patient FAQ & Clinical Guidance
1. What is the DCX gene test, and why is it performed?
Snippet Answer: The DCX NGS test sequences the entire coding region of the DCX gene to detect pathogenic variants responsible for X‑linked lissencephaly type 1 and subcortical band heterotopia, enabling accurate diagnosis and family‑wide genetic counselling.
This test is ordered when clinical features (agyria/pachygyria on MRI, developmental delay, epilepsy) and family history suggest DCX‑related neuronal migration disorder. It helps distinguish classic lissencephaly from other cortical malformations and guides prognosis and reproductive options.
2. How is the sample collected for this test in the UAE?
Snippet Answer: A DHA‑licensed phlebotomist visits your home at a scheduled slot to perform a simple blood draw (3‑5 mL in EDTA tube) or collect a DNA FTA card, followed by ISO‑certified cold‑chain transport to our central laboratory.
All home collections for minors strictly adhere to the UAE Child Protection (CDS) Law 2026, requiring parental consent and a pediatrician referral. Samples are accepted from 8 AM to 11 PM, seven days a week, with results delivered via secure patient portal.
3. What do the results mean, and what support is available?
Snippet Answer: A positive result confirms a pathogenic variant in DCX, providing a definitive aetiology for the brain malformation and guiding early intervention; a negative result rules out DCX‑related lissencephaly but does not exclude other genetic causes, which our team will explain in detail.
All reports include variant classification per ACMG 2026 guidelines. A complimentary telephonic post‑test consultation with a certified genetic counsellor is provided. For further genetic evaluation, we can facilitate referral to paediatric neurology or clinical genetics services within UAE healthcare networks, in compliance with Federal Decree‑Law No. 41 of 2024 (Art. 87) and UAE PDPL.
UAE Regulatory Compliance & Accreditation
- Medical testing and reporting performed under Federal Decree‑Law No. 41 of 2024, Article 87, with strict adherence to patient safety and result accuracy standards.
- Collection from minors complies with the Child Rights Law (CDS Law 2026); valid parental/guardian consent mandatory.
- All personal health data processed per UAE Personal Data Protection Law (PDPL), ensuring encrypted transfer and storage.
- ISO 9001:2015 certified facility (Certificate: INT/EGQ/2509DA/3139) – DHA Licence No. 9834453.
- Pre‑test genetic counselling session and pedigree chart review strongly recommended to optimise interpretation (available via WhatsApp booking).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians